This inventor holds 2 USPTO granted patents. Top assignees: Glaxo Group Limited, Ingenza Limited. Active years: 2007-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2012
Title: Innovations and Contributions of Inventor Alexis Enright
Introduction
Alexis Enright is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of chemistry, particularly in the area of chiral amines. With a total of 2 patents to his name, his work has garnered attention for its innovative approaches and practical applications.
Latest Patents
One of Alexis Enright's latest patents focuses on the deracemization of amines. This invention relates to a method for the deracemization or chiral inversion of chiral amines through enzymatic treatment. The method employs a stereoselective enzymatic conversion, along with either a non-selective or partially selective chemical or enzymatic conversion, which can occur simultaneously or sequentially. Additionally, the invention provides a method for selecting a suitable enzyme, particularly an amine oxidase, and for generating novel enzymes that are suitable for use in the deracemization process.
Career Highlights
Throughout his career, Alexis Enright has worked with prominent companies such as Glaxo Group Limited and Ingenza Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in the field of biochemistry.
Collaborations
Some of his notable coworkers include Marina Victorovna Alexeeva and Mahmoud Mahmoudian. Their collaborative efforts have likely played a role in the development of his patents and innovations.
Conclusion
In summary, Alexis Enright is an accomplished inventor whose work in the deracemization of amines showcases his innovative spirit and dedication to advancing chemical processes. His contributions continue to influence the field and inspire future research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
